NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.85
+1.95%Oct 15, 2026, 13:18 UTC
Neuraxis, INC announced a medical policy coverage milestone that adds coverage for PENFS for 26 million people, bringing its national coverage footprint to more than 147 million covered lives.
Source:Sep 29, 2026, 11:00 UTC
NeurAxis, Inc. appointed Craig Blanchard as its Chief Commercial Officer.
Source:Sep 16, 2026, 13:00 UTC
NeurAxis announced that a major national health insurer issued a new medical policy covering its PENFS neuromodulation therapy, expanding access to over 18 million additional covered lives.
Source:Aug 19, 2026, 00:00 UTC
Neuraxis, Inc. granted restricted stock units to executives Brian Carrico, Adrian Miranda, and Thomas Carrico on July 24, 2026, as part of their compensation packages.
Aug 11, 2026, 18:47 UTC
NeurAxis, Inc. held its Q2 2026 earnings call on August 11, 2026.
Source: